PTPA and neoplasm: Although inhibition of PP1 or PP2A has some effects on reduced tumor resistance to radiation or chemotherapy (Hamilton et al., 2009; Lu et al., 2009), it is difficult to apply protein phosphatase inhibitors for cancer therapy because they also affect many other cellular events in vivo.